Apr 05, 2012 10:58 PM IST | Source: CNBC-TV18

Biocon expands its R&D facility in Bangalore

Bio-pharma major Biocon on expansion mode.

Bio-pharma major Biocon is on an expansion mode. The biotech major plans to invest close to Rs 100 crore on its new research and development center located in Bangalore, with a window for future investments going up to Rs 200 crore in next few years.

Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
Kiran Mazumdar-Shaw, chairman and managing director, Biocon
says, the big change in our strategy would be that from having one global partner which was Pfizer, we'll have multiple partners.

Follow us on
Available On